Fred Aslan
Director, Chief Executive Officer; Director, President and CEO · 2 filings · Latest: May 19, 2026
Artiva Biotherapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ARTV | Fred Aslan | Director, Chief Executive Officer | May 19, 2026 | Sale | $9.01 | 27,116 | $244.3K | 1,535,082 | |
ARTV | Fred Aslan, M.D. | — | May 18, 2026 | Proposed Sale | $9.22 | 28,000 | $258.2K | — | |
ARTV | FRED ASLAN | — | Dec 15, 2025 | Proposed Sale | $3.30 | 12,749 | $42.1K | — | |
ARTV | FRED ASLAN | — | Nov 17, 2025 | Proposed Sale | $3.25 | 6,375 | $20.7K | — | |
ARTV | FRED ASLAN | — | Oct 17, 2025 | Proposed Sale | $2.77 | 25,500 | $70.6K | — | |
ARTV | FRED ASLAN | — | Aug 15, 2025 | Proposed Sale | $2.70 | 25,500 | $68.8K | — |